Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Uterine Cervical Neoplasms"" wg kryterium: Temat


Tytuł :
Letter to the editor.
Autorzy :
Thamsborg LH; Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1014 Copenhagen K, Denmark. Electronic address: .
Napolitano G; Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1014 Copenhagen K, Denmark. Electronic address: .
Lynge E; Nykoebing Falster Hospital, Hospitalsvej, 4800 Nykoebing Falster, Denmark; Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1014 Copenhagen K, Denmark. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Sep 30; Vol. 37 (42), pp. 6133.
Typ publikacji :
Letter; Comment
MeSH Terms :
Papillomavirus Infections*
Uterine Cervical Neoplasms*
Early Detection of Cancer ; Ethnic Groups ; Female ; Humans ; Vaccination
Opinia redakcyjna
Tytuł :
Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
Autorzy :
Russ SM; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, United States. Electronic address: .
Brackney M; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, United States. Electronic address: .
Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, United States. Electronic address: .
Niccolai LM; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Jul 18; Vol. 37 (31), pp. 4262-4267. Date of Electronic Publication: 2019 Jun 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Vaccination*
Papillomavirus Infections/*complications
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*epidemiology
Uterine Cervical Neoplasms/*etiology
Adult ; Cervical Intraepithelial Neoplasia/diagnosis ; Cervical Intraepithelial Neoplasia/epidemiology ; Cervical Intraepithelial Neoplasia/etiology ; Cervical Intraepithelial Neoplasia/prevention & control ; Connecticut/epidemiology ; Female ; Humans ; Incidence ; Insurance, Health ; Outcome Assessment, Health Care ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/prevention & control ; Papillomavirus Vaccines/administration & dosage ; Prevalence ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
Autorzy :
Taniguchi M; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Ueda Y; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. Electronic address: .
Yagi A; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Ikeda S; Dept. of Gynecology, International University of Health and Werfare Mita Hospital, 1-4-3 Mita, Minato-ku Tokyo, 108-8329 Japan.
Endo M; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Tomimatsu T; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Nakayama T; Center for Public Health Sciences, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Sekine M; Dept. of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Enomoto T; Dept. of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Kimura T; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Jul 26; Vol. 37 (32), pp. 4424-4426. Date of Electronic Publication: 2019 Jul 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Early Detection of Cancer/*statistics & numerical data
Mass Screening/*statistics & numerical data
Papillomavirus Infections/*immunology
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*diagnosis
Vaccination/*statistics & numerical data
Adult ; Female ; Humans ; Incidence ; Japan ; Papillomaviridae/immunology ; Papillomavirus Infections/virology ; Surveys and Questionnaires ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
Autorzy :
Markowitz LE; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: .
Naleway AL; Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA.
Lewis RM; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA; Synergy America, Inc., Duluth, GA 30097, USA.
Crane B; Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA.
Querec TD; National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Weinmann S; Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA.
Steinau M; National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Unger ER; National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Jun 27; Vol. 37 (29), pp. 3918-3924. Date of Electronic Publication: 2019 May 31.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Immunity, Herd*
Papillomavirus Infections/*virology
Papillomavirus Vaccines/*administration & dosage
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*virology
Vaccination/*statistics & numerical data
Adult ; Cytological Techniques ; Female ; Genotype ; Humans ; Papillomaviridae/classification ; Papillomavirus Infections/prevention & control ; Prevalence ; United States ; Uterine Cervical Neoplasms/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Evaluation of future cervical cancer risk in Japan, based on birth year.
Autorzy :
Yagi A; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Ueda Y; Dept. of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. Electronic address: .
Ikeda S; Dept. of Gynecology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, 1-7-1 Aoba-cho, Higashimurayama, Tokyo 189-8511, Japan.
Sekine M; Dept. of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Nakayama T; Center for Public Health Sciences, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Miyagi E; Dept. of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.
Enomoto T; Dept. of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 May 16; Vol. 37 (22), pp. 2889-2891. Date of Electronic Publication: 2019 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cervical Intraepithelial Neoplasia/*epidemiology
Cervical Intraepithelial Neoplasia/*prevention & control
Uterine Cervical Neoplasms/*epidemiology
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Cervical Intraepithelial Neoplasia/immunology ; Early Detection of Cancer ; Female ; Humans ; Incidence ; Japan/epidemiology ; Papillomavirus Vaccines/therapeutic use ; Uterine Cervical Neoplasms/immunology
Czasopismo naukowe
Tytuł :
HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
Autorzy :
Edler M; University of South Alabama Children & Women's Hospital, 1700 Center Street, Mobile, AL 36604, USA.
Fernandez A; University of South Alabama Mitchell Cancer Institute, 1660 Springhill Avenue, Mobile, AL 36604, USA.
Anderson K; University of South Alabama, 307 North University Boulevard, Mobile, AL 36688, USA.
Pierce JY; University of South Alabama Mitchell Cancer Institute, 1660 Springhill Avenue, Mobile, AL 36604, USA. Electronic address: .
Scalici J; University of South Alabama Mitchell Cancer Institute, 1660 Springhill Avenue, Mobile, AL 36604, USA. Electronic address: .
Daniel CL; University of South Alabama Mitchell Cancer Institute, 1660 Springhill Avenue, Mobile, AL 36604, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Jan 21; Vol. 37 (4), pp. 550-557. Date of Electronic Publication: 2018 Dec 28.
Typ publikacji :
Journal Article
MeSH Terms :
Health Knowledge, Attitudes, Practice*
Cancer Survivors/*psychology
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*prevention & control
Adult ; Cancer Survivors/statistics & numerical data ; Female ; Humans ; Patient Acceptance of Health Care ; Qualitative Research ; Retrospective Studies ; Southeastern United States ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
Autorzy :
Konno R; Department of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, Omiya-ku, Saitama 330-8503, Japan. Electronic address: .
Konishi H; Japan Cancer Society, Tokyo, Japan.
Sauvaget C; Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Kakizoe T; Japan Cancer Society, Tokyo, Japan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Dec 18; Vol. 36 (52), pp. 7913-7915. Date of Electronic Publication: 2018 May 21.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cervical Intraepithelial Neoplasia/*prevention & control
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*therapeutic use
Uterine Cervical Neoplasms/*prevention & control
Vaccination/*statistics & numerical data
Adult ; Cervical Intraepithelial Neoplasia/diagnosis ; Cohort Studies ; Female ; Humans ; Japan ; Mass Screening ; Regression Analysis ; Uterine Cervical Neoplasms/diagnosis ; Vaccine Potency ; Young Adult
Czasopismo naukowe
Tytuł :
Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
Autorzy :
Dehlendorff C; Statistics and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark. Electronic address: .
Sparén P; Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Baldur-Felskov B; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Herweijer E; Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Arnheim-Dahlström L; Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Ploner A; Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Uhnoo I; Dept. of Monitoring and Evaluation, Public Health Agency of Sweden, Stockholm, Sweden.
Kjaer SK; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Oct 15; Vol. 36 (43), pp. 6373-6378. Date of Electronic Publication: 2018 Sep 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunization Schedule*
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/*administration & dosage
Papillomavirus Infections/*prevention & control
Uterine Cervical Dysplasia/*prevention & control
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Adult ; Cohort Studies ; Denmark/epidemiology ; Female ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/therapeutic use ; Humans ; Sweden/epidemiology ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
Autorzy :
Smith MA; Cancer Research Division, Cancer Council NSW, Sydney, Australia. Electronic address: .
Hall M; Cancer Research Division, Cancer Council NSW, Sydney, Australia. Electronic address: .
Lew JB; Cancer Research Division, Cancer Council NSW, Sydney, Australia. Electronic address: .
Canfell K; Cancer Research Division, Cancer Council NSW, Sydney, Australia; School of Public Health, University of Sydney, Sydney, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Oct 08; Vol. 36 (42), pp. 6314-6324. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Uterine Cervical Neoplasms/*prevention & control
Vaccination/*methods
Cervical Intraepithelial Neoplasia/immunology ; Cervical Intraepithelial Neoplasia/prevention & control ; Cervical Intraepithelial Neoplasia/virology ; Early Detection of Cancer ; Female ; Humans ; New Zealand ; Papillomavirus Infections/immunology ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/therapeutic use ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
Autorzy :
Skufca J; Department of Health Security, Infectious Diseases Control and Vaccinations Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Ollgren J; Department of Health Security, Infectious Diseases Control and Vaccinations Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Artama M; Department of Public Health Solutions, Public Health Evaluation and Projection Unit, National Institute for Health and Welfare (THL), Tampere, Finland. Electronic address: .
Ruokokoski E; Department of Health Security, Infectious Diseases Control and Vaccinations Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Nohynek H; Department of Health Security, Infectious Diseases Control and Vaccinations Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Palmu AA; Department of Public Health Solutions, Public Health Evaluation and Projection Unit, National Institute for Health and Welfare (THL), Tampere, Finland.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Sep 18; Vol. 36 (39), pp. 5926-5933. Date of Electronic Publication: 2018 Aug 13.
Typ publikacji :
Journal Article
MeSH Terms :
Registries*
Adverse Drug Reaction Reporting Systems/*statistics & numerical data
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*adverse effects
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Autoimmune Diseases/epidemiology ; Autoimmune Diseases/etiology ; Child ; Cohort Studies ; Female ; Finland/epidemiology ; Human papillomavirus 16 ; Human papillomavirus 18 ; Humans ; Immunization Programs ; Papillomavirus Vaccines/administration & dosage ; Proportional Hazards Models ; Retrospective Studies ; Uterine Cervical Neoplasms/virology ; Vaccination Coverage/statistics & numerical data
Czasopismo naukowe
Tytuł :
National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
Autorzy :
Gamaoun R; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia; Epidemiology and Preventive Medicine Department, Fattouma-Bourguiba University Hospital, Monastir, Tunisia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 09; Vol. 36 (33), pp. 5091-5096. Date of Electronic Publication: 2018 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Papillomavirus Vaccines/*therapeutic use
Uterine Cervical Neoplasms/*prevention & control
Uterine Cervical Neoplasms/*virology
Arabs ; Cost-Benefit Analysis ; Female ; Humans ; Immunization Programs/economics ; Immunization Programs/methods ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Tunisia ; Uterine Cervical Neoplasms/diagnosis ; Vaccination/economics ; Vaccination/methods ; Vaginal Smears
Czasopismo naukowe
Tytuł :
Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
Autorzy :
Tan N; Department of Global Health, University of Washington, Seattle, WA, USA.
Sharma M; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Winer R; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Galloway D; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; School of Medicine, University of Washington, Seattle, WA, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Rees H; Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa.
Barnabas RV; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; School of Medicine, University of Washington, Seattle, WA, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt A), pp. 4830-4836. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunization Schedule*
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*mortality
Uterine Cervical Neoplasms/*prevention & control
Uterine Cervical Neoplasms/*therapy
Adult ; Age Factors ; Child ; Cost-Benefit Analysis ; Female ; HIV Infections/epidemiology ; HIV Infections/mortality ; Humans ; Incidence ; Mass Vaccination ; Models, Theoretical ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/therapy ; Papillomavirus Vaccines/therapeutic use ; Prevalence ; South Africa/epidemiology ; Treatment Outcome ; Uterine Cervical Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
Autorzy :
Stanley M; Department of Pathology, University of Cambridge, UK. Electronic address: .
Dull P; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt A), pp. 4759-4760. Date of Electronic Publication: 2018 May 10.
Typ publikacji :
Editorial
MeSH Terms :
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/*administration & dosage
Human papillomavirus 16/*immunology
Human papillomavirus 18/*immunology
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Animals ; Female ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/therapeutic use ; Humans ; Immunization Schedule ; Papillomavirus Infections/therapy ; Papillomavirus Vaccines/therapeutic use ; Program Evaluation ; Uterine Cervical Neoplasms/therapy ; Vaccination Coverage ; Young Adult
Opinia redakcyjna
Tytuł :
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.
Autorzy :
Sankaranarayanan R; Screening Group, International Agency for Research on Cancer, Lyon, France. Electronic address: .
Joshi S; Jehangir Clinical Development Centre, Jehangir Hospital, Pune, India.
Muwonge R; Screening Group, International Agency for Research on Cancer, Lyon, France.
Esmy PO; Christian Fellowship Community Health Centre, Ambillikai, India.
Basu P; Screening Group, International Agency for Research on Cancer, Lyon, France.
Prabhu P; Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, India.
Bhatla N; All India Institute of Medical Sciences, New Delhi, India.
Nene BM; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Barshi, Solapur District, Maharashtra, India.
Shaw J; Gujarat Cancer and Research Institute, MP Shaw Cancer Hospital, Ahmedabad, India.
Poli URR; Mehdi Nawaj Jung Institute of Oncology and Regional Cancer Center, Red Hills, Lakadikapul, Hyderabad, Andhra Pradesh, India.
Verma Y; Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim, India.
Zomawia E; Civil Hospital, Aizawl, Mizoram, India.
Pimple S; Department of Preventive Oncology, Tata Memorial Centre, Parel, Mumbai, India.
Tommasino M; Infections and Cancer Biology Group, Infections Section, International Agency for Research on Cancer, Lyon, France.
Pawlita M; Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.
Gheit T; Infections and Cancer Biology Group, Infections Section, International Agency for Research on Cancer, Lyon, France.
Waterboer T; Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.
Sehr P; EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
Pillai MR; Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, India.
Pokaż więcej
Corporate Authors :
Indian HPV vaccine study group
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt A), pp. 4783-4791. Date of Electronic Publication: 2018 Mar 15.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/*administration & dosage
Human papillomavirus 16/*immunology
Human papillomavirus 18/*immunology
Papillomavirus Infections/*prevention & control
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Antibodies, Neutralizing/immunology ; Antibody Affinity/immunology ; Child ; Female ; Follow-Up Studies ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/therapeutic use ; Humans ; Immunization Schedule ; Immunogenicity, Vaccine/immunology ; India/epidemiology ; Papillomavirus Infections/epidemiology ; Time Factors ; Uterine Cervical Neoplasms/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
Autorzy :
Burger EA; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, 718 Huntington Ave, 2ndFloor, Boston, MA 02117, USA; University of Oslo, Department of Health Management and Health Economics, Postboks 1089, Blindern, 0317 Oslo, Norway. Electronic address: .
Campos NG; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, 718 Huntington Ave, 2ndFloor, Boston, MA 02117, USA.
Sy S; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, 718 Huntington Ave, 2ndFloor, Boston, MA 02117, USA.
Regan C; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, 718 Huntington Ave, 2ndFloor, Boston, MA 02117, USA.
Kim JJ; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, 718 Huntington Ave, 2ndFloor, Boston, MA 02117, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt A), pp. 4823-4829. Date of Electronic Publication: 2018 May 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunization Schedule*
Delivery of Health Care/*economics
Mass Vaccination/*economics
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Child ; Cost-Benefit Analysis ; Female ; Human papillomavirus 16/immunology ; Human papillomavirus 18/immunology ; Humans ; Papillomavirus Infections/epidemiology ; Papillomavirus Vaccines/therapeutic use ; Quality-Adjusted Life Years ; Uganda/epidemiology ; Uterine Cervical Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
Autorzy :
Markowitz LE; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Drolet M; Centre de recherche du CHU de Québec - Université Laval, Axe santé des populations et pratiques optimales en santé, Québec, Canada.
Perez N; Centre de recherche du CHU de Québec - Université Laval, Axe santé des populations et pratiques optimales en santé, Québec, Canada.
Jit M; Modelling and Economics Unit, Public Health England, London, United Kingdom; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Brisson M; Centre de recherche du CHU de Québec - Université Laval, Axe santé des populations et pratiques optimales en santé, Québec, Canada; Department of Infectious Disease Epidemiology, Imperial College, London, United Kingdom; Département de médecine sociale et préventive, Université Laval, Québec, Canada.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 06; Vol. 36 (32 Pt A), pp. 4806-4815. Date of Electronic Publication: 2018 May 22.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Immunization Schedule*
Immunization, Secondary/*statistics & numerical data
Mass Vaccination/*statistics & numerical data
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Adult ; Female ; Humans ; Papillomavirus Infections/epidemiology ; Papillomavirus Vaccines/therapeutic use ; Prevalence ; Risk Factors ; Uterine Cervical Neoplasms/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
Autorzy :
Bonner K; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.
Banura C; Child Health and Development Centre, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Basta NE; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Jan 04; Vol. 36 (2), pp. 191-193. Date of Electronic Publication: 2017 Dec 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Services Needs and Demand*
Schools*
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*prevention & control
Vaccination/*methods
Adolescent ; Child ; Delivery of Health Care/standards ; Female ; Health Plan Implementation/methods ; Humans ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/virology ; School Health Services ; Sex Factors ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Autorzy :
Võrno T; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia. Electronic address: .
Lutsar K; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Uusküla A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Padrik L; Tartu University Hospital, Women's Clinic, Tartu, Estonia.
Raud T; Tartu University Hospital, Women's Clinic, Tartu, Estonia.
Reile R; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Nahkur O; Institute of Social Studies, University of Tartu, Tartu, Estonia.
Kiivet RA; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2017 Nov 01; Vol. 35 (46), pp. 6329-6335. Date of Electronic Publication: 2017 Sep 09.
Typ publikacji :
Journal Article
MeSH Terms :
Cost-Benefit Analysis*
Papillomavirus Infections/*complications
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*economics
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*economics
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anus Neoplasms/economics ; Anus Neoplasms/epidemiology ; Anus Neoplasms/prevention & control ; Child ; Estonia/epidemiology ; Female ; Humans ; Incidence ; Middle Aged ; Models, Statistical ; Mouth Neoplasms/economics ; Mouth Neoplasms/epidemiology ; Mouth Neoplasms/prevention & control ; Oropharyngeal Neoplasms/economics ; Oropharyngeal Neoplasms/epidemiology ; Oropharyngeal Neoplasms/prevention & control ; Papillomavirus Infections/epidemiology ; Papillomavirus Vaccines/administration & dosage ; Uterine Cervical Neoplasms/epidemiology ; Vaginal Neoplasms/economics ; Vaginal Neoplasms/epidemiology ; Vaginal Neoplasms/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Autorzy :
Lim ASE; Preventive Medicine Resident, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore. Electronic address: .
Lim RBT; Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, Singapore 117549, Singapore.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Sep 24; Vol. 37 (41), pp. 6030-6038. Date of Electronic Publication: 2019 Aug 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Knowledge, Attitudes, Practice*
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*therapeutic use
Patient Acceptance of Health Care/*psychology
Patient Acceptance of Health Care/*statistics & numerical data
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Adult ; Female ; Focus Groups ; Human papillomavirus 16/immunology ; Human papillomavirus 18/immunology ; Humans ; Immunization Programs ; Papillomavirus Vaccines/economics ; Preventive Health Services ; Qualitative Research ; Singapore ; Vaccination/economics ; Vaccination/statistics & numerical data ; Young Adult
Czasopismo naukowe
Tytuł :
Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).
Autorzy :
Hirth JM; Center for Interdisciplinary Research in Women's Health, Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: .
Kuo YF; Department of Biostatistics and Epidemiology, University of Texas Medical Branch, Galveston, TX, United States.
Starkey JM; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, United States.
Rupp RE; Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Laz TH; Department of Radiology, St. Luke's International Hospital, Tokyo, Japan.
Rahman M; Division of Epidemiology, Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
Berenson AB; Center for Interdisciplinary Research in Women's Health, Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX, United States.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Jul 09; Vol. 37 (30), pp. 4040-4046. Date of Electronic Publication: 2019 Jun 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Papillomaviridae/*pathogenicity
Papillomavirus Infections/*epidemiology
Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Humans ; Logistic Models ; Papillomaviridae/immunology ; Papillomavirus Infections/prevention & control ; Papillomavirus Vaccines/therapeutic use ; Prevalence ; Uterine Cervical Neoplasms/prevention & control ; Uterine Cervical Neoplasms/virology ; Vaccination/statistics & numerical data ; Vagina/virology ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies